Quarterly report pursuant to Section 13 or 15(d)

Note 13 - Intangible Assets, Net (Tables)

v3.23.3
Note 13 - Intangible Assets, Net (Tables)
9 Months Ended
Sep. 30, 2023
Notes Tables  
Schedule of Finite-Lived Intangible Assets [Table Text Block]
   

September 30, 2023

   

December 31, 2022

 
   

(Unaudited)

   

(Audited)

 

Pharmacy records

  $ 8,100,000     $ -  

Trade names

    4,060,000       -  

Developed technology

    2,560,000       -  

Customer Contracts

    250,000       250,000  

Subtotal

  $ 14,970,000     $ 250,000  

Less: accumulated amortization

    (853,252 )     (199,999 )

Net intangible assets

  $ 14,116,748     $ 50,001  
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Year

    Amount  

2023 (remaining three months)

  $ 640,748  

2024

    2,563,000  

2025

    2,538,000  

2026

    2,538,000  

2027

    2,538,000  

Thereafter

    3,299,000  

Total

  $ 14,116,748